Parliamentary questions
Margaret McDougall
364 questions tabled in the Scottish Parliament, most recent first.
9 Jun 2011 · Written Question
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with the Scotland Office regarding the location of GlaxoSmithKline's proposed new plant.
Answer · John Swinney: The Scottish Government has not had discussions, correspondence or meetings with the Scotland Office regarding the location of GlaxoSmithKline’s (GSK) proposed new plant. However, when the criteria for the site selection process is released by GSK, in early J…
9 Jun 2011 · Written Question
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with North Ayrshire Council regarding the location of GlaxoSmithKline's proposed new plant.
Answer · John Swinney: Anne MacColl, Chief Executive of Scottish Development International (SDI) met with Elma Murray, Chief Executive of North Ayrshire Council on 16 May 2011. One of the items discussed was the proposed location of the new GlaxoSmithKline (GSK) plant. It was confi…
9 Jun 2011 · Written Question
To ask the Scottish Executive how it supports job creation in North Ayrshire.
Answer · Fergus Ewing: A wide range of support and services is available in North Ayrshire to support job creation. The primary driver for economic growth and job creation in North Ayrshire is the Irvine Bay Urban Regeneration Company (URC). Grant funding of £4 million has been pro…
9 Jun 2011 · Written Question
To ask the Scottish Executive what (a) discussions, (b) correspondence and (c) meetings it has had with GlaxoSmithKline regarding the location of its proposed new plant.
Answer · John Swinney: Andrew Witty, CEO of GlaxoSmithKline (GSK), confirmed in a letter to the First Minister on 9 May 2011 that Scotland was being considered as a location for its new biopharmaceutical manufacturing plant. The Scottish Government has been advised by GSK that the …